Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Open accessPublished version of a preprint
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The efficacy of virus-specific T cells in clearing pathogens involves a fine balance between antiviral and inflammatory features. SARS-CoV-2–specific T cells in individuals who clear SARS-CoV-2 without symptoms could reveal nonpathological yet protective characteristics. We longitudinally studied SARS-CoV-2–specific T cells in a cohort of asymptomatic (n = 85) and symptomatic (n = 75) COVID-19 patients after seroconversion. We quantified T cells reactive to structural proteins (M, NP, and Spike) using ELISpot and cytokine secretion in whole blood. Frequencies of SARS-CoV-2–specific T cells were similar between asymptomatic and symptomatic individuals, but the former showed an increased IFN-γ and IL-2 production. This was associated with a proportional secretion of IL-10 and proinflammatory cytokines (IL-6, TNF-α, and IL-1β) only in asymptomatic infection, while a disproportionate secretion of inflammatory cytokines was triggered by SARS-CoV-2–specific T cell activation in symptomatic individuals. Thus, asymptomatic SARS-CoV-2–infected individuals are not characterized by weak antiviral immunity; on the contrary, they mount a highly functional virus-specific cellular immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in COVID-19 acute, mild and convalescent patients [110, 118-125].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [125]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dimensionality reduction for visualizing single-cell data using UMAP
Becht, E., McInnes, L., Healy, J., Dutertre, C.-A., Kwok, I. W. H., Ng, L. G., Ginhoux, F., & Newell, E. W. (2019) · Nature Biotechnology · doi:10.1038/nbt.4314 · Cited by 5,358
Self-citationGrifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Self-citationClinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
IL-10: The Master Regulator of Immunity to Infection
Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,223
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074
Self-citationSARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Self-citationRydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674 · cited 1×
“specific B cells progressively evolved after COVID-19 recovery due to the presence of SARS8 CoV-2 antigen in the small bowel (27), makes such hypothesis even more plausible.”
Background
Cited by
Items 301–326 of 326
Сергеевич, Ч. Б., Kudryashova, A. M., Pankratyeva, L. L., Васильевна, Б. А., Manuylov, V. A., Gushchin, V. А., Pochtovyi, A. A., Borisova, O. V., & Свитич, О. А. (2024) · Medical Immunology (Russia) · doi:10.15789/1563-0625-dot-3007
Ramania, N. S., APRIANTONO, T. A., Winata, B., Syafriani, R., Bahri, S., Iwo, M. I., & Nugraha, A. B. (2025) · Physiotherapy Quarterly · doi:10.5114/pq/182853
T cell immunity induced by SARS-CoV-2 and flavivirus vaccination
Wullimann, D. (2025) · doi:10.69622/28287788.v1
Kalia, V., Ahmed, R., & Sarkar, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00292-1
Oliveira, B. C. D., Macedo, A. B., Jacinto, R. A., Macedo, I. B., Santos, G. C., da Câmara, L. A. F. C., & Mattos, C. P. (2025) · Research Society and Development · doi:10.33448/rsd-v14i11.49986
Taus, E., Shino, M. Y., Ibarrondo, F. J., Hausner, M. A., Hofmann, C., & Yang, O. O. (2024) · Figshare · doi:10.6084/m9.figshare.26595695
SARS-COV-2 PATHOGENESIS AND THE HOST IMMUNE RESPONSE
Imbiakha, B. (2023) · eCommons (Cornell University) · doi:10.7298/fwwj-hr68
Taus, E., Shino, M. Y., Ibarrondo, F. J., Hausner, M. A., Hofmann, C., & Yang, O. O. (2024) · Figshare · doi:10.6084/m9.figshare.26595698
Leveraging SARS-CoV-2-induced pre-existing humoral and cellular immunity for tumor elimination
Chen, L., Yu, Q., Duan, S., Mao, Q., Han, Y., Tang, S., Yao, W., Gao, X., & Tian, H. W. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116114
Filho, R. V. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Yang, G., Cao, J., Deng, S., Xia, Y., Zhao, J., Qin, J., Yang, X., Sun, M., Chen, D., Sun, P., et al. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag050
“Multifunctional virus-specific T cells have been reported to mediate the early clearance of SARS-CoV-2 and be associated with mild infections [20].”
Allannavar, S., Astagimath, M. N., Bargale, A. B., Doddamani, S., Kulkarni, S. P., Hiremath, S., Alagilavada, S., & Kamath, C. (2026) · Acta Medica International · doi:10.21276/amit.2026.v13.i1.320
The Effects of Pegylated Interferon-Lambda Treatment on SARS-CoV-2-specific T Cell Responses
Li, D. (2022) · TSpace (University of Toronto)
Evaluation of serum pro-inflammatory cytokines (TNF and IL-6) in patients with giardiasis
Kheiruralla, I. A., Jaffar, A. M., Kamil, S. S., & Al-fahham, A. A. (2026) · AIP conference proceedings · doi:10.1063/5.0322336
Abdullah, M., Naz, A., Reznikov, L. R., Qureshi, J. A., Hasnain, A., Obaid, A., & Ali, A. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1763029
Li, S., Zi, Q., Fan, J., Jiang, G., Zhang, Y., Feng, D., Nur, Z., Liu, X., Lai, J., Chen, T., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04326-0
Caractérisation des activités antivirales des anticorps anti-VIH-1 et anti-SARS-CoV-2
Dufloo, J. (2021) · theses.fr (ABES) · doi:10.70675/215798eaz7f82z4e57za8eazf4453d37b8c8
Hernandez, S. P. A., Munk, K. K., Danilov, K., Kadivar, M., Hersby, D. S., Tamhane, T., Stegenborg-Grathwohl, S. M., Pedersen, A. G., Gang, A. O., Hadrup, S. R., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106310
Santos, A. D. S., de Araújo, L. P., Orts, D. J. B., da Costa, H. H. M., Matteucci, K. C., Silva, E. N., Oliveira, K. C., Galdino, G., Prudêncio, C. R., Corsetti, P. P., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1775087
Health and Well-Being: Theoretical and Methodological Connotations
Karadimas, P. (2026) · Methodos series · doi:10.1007/978-3-032-28597-3_4
Prakash, S., Dhanushkodi, N. R., Quadiri, A., Vahed, H., Chentoufi, A. A., Coulon, P.-G. A., Ibraim, I. C., Babsiri, A. E., Tifrea, D. F., Figueroa, C. J., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01549-y
“NSP-4(527aa)isabifunctionalprotein;theN-terminal domain has a methyltransferase function required for virus replication 81 – 83 , andtheC-terminaldomainhasaproofreadingexonucleasefunctioninviral RNA5 ′ capping and facilitates viral mRNA stability and translation 82,84 – 86 .”
Srivastava, R., Prakash, S., Karan, S., & BenMohamed, L. (2026) · Viruses · doi:10.3390/v18090940
“…frequencies of antigen-specific T cells in asymptomatic and symptomatic individuals, but asymptomatic individuals showed proportionate secretion of IFN-γ , IL-10, and pro-inflammatory cytokines (IL-6, TNF-α , IL-1 β ), whereas their secretion was disproportionate in symptomatic individuals [6–8].”
Kandel, C. E., Breznik, J. A., Taylor, M., Colwill, K., Hu, Q., Llanes, A., Crowl, G., Elliott, H. D., Shi, G., Li, X. A., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101500
Robust T and B cell activation is associated with rapid clearance of infectious SARS-CoV-2Preprint
Zemelko, L., Tibúrcio, R., Wang, Y. Y., Constantz, C. M., Borgo, G. M., Chen, W., Spitzer, M. H., Anglin, K., Lu, S., Goldberg, S. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.04.763820
Metadata
- Authors
- Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y. L., Lim, J. M., Kunasegaran, K., Tan, L. W. L., Dutertre, C.-A., Shankar, N., Lim, J. M. E., Sun, L. J., Zahari, M., Tun, Z. M., Kumar, V., Lim, B. L., Lim, S. H., Chia, A., Tan, Y.-J., Tambyah, P. A., Kalimuddin, S., Lye, D., Low, J. G. H., Wang, L.-F., Wan, W. Y., Hsu, L. Y., Bertoletti, A., & Tam, C. C.
- Affiliations
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 1
- National University of Singapore (SG)
- Inserm (FR)
- Alexandra Hospital (SG)
- Singapore General Hospital (SG)
- Agency for Science, Technology and Research (SG)
- National University Hospital (SG)
- Corresponding author
- Bertoletti, Antonio
- ORCID
- Le Bert, Nina
- Clapham, Hannah E.
- Tan, Anthony T.
- Chia, Wan Ni
- Tham, Christine Y.L.
- Lim, Jane M.
- Kunasegaran, Kamini
- Tan, Linda Wei Lin
- Dutertre, Charles-Antoine
- Shankar, Nivedita
- Lim, Joey M.E.
- Sun, Louisa Jin
- Zahari, Marina
- Tun, Zaw Myo
- Kumar, Vishakha
- Lim, Beng Lee
- Lim, Siew Hoon
- Chia, Adeline
- Tan, Yee-Joo
- Tambyah, Paul Anantharajah
- Kalimuddin, Shirin
- Lye, David
- Low, Jenny G.H.
- Wang, Lin-Fa
- Wan, Wei Yee
- Hsu, Li Yang
- Bertoletti, Antonio
- Tam, Clarence C.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2021-03-01
- Volume
- 218
- Issue
- 5
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC7927662
- OpenAlex
- W3134489892
- Cited by
- 330
- References
- 38
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 45 · 2023: 68 · 2022: 110 · 2021: 74
- FWCI
- 23.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National University Health System (NUHSRO/2020/052/RO5+5/NUHS-COVID/6)
- Saw Swee Hock School of Public Health
- National University of Singapore
- National Research Foundation Singapore (NRF2016NRF-NSFC002-013)
- National Medical Research Council
- Ministry of Health - Singapore (STPRG-FY19-001, COVID19RF-003, COVID19RF3-0060)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, asymptomatic infection, virus-specific T cells, cell-mediated immunity, interferon-gamma, interleukin-2, IL-10, inflammatory cytokines, cytokine production, spike protein, nucleocapsid protein, matrix protein, T cell activation, seroconversion
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Humans, Lymphocyte Activation, Male, Middle Aged, T-Lymphocytes, Cytokines, Asymptomatic Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.